查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948979

整形外科義肢市場（材料類型、應用、產品類型和最終用戶分類），全球預測（2026-2032）

Orthopedic Forged Protheses Market by Material Type, Application, Product Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年整形外科鍛造關節假體市值為63.4億美元，預計2026年將成長至68.9億美元，年複合成長率為9.58%，到2032年將達到120.4億美元。

關鍵市場統計數據
基準年 2025 63.4億美元
預計年份：2026年 68.9億美元
預測年份 2032 120.4億美元
複合年成長率 (%) 9.58%

這是一份簡明的策略指南，整合了臨床、製造和供應趨勢，為整形外科矯形人工替代物領域的商業決策提供支援。

整形外科骨科人工替代物領域正處於外科創新、材料科學和複雜供應鏈動態的關鍵交匯點。冶金、精密製造和植入設計方面的進步，使得臨床需求與商業性需求趨於一致：外科醫生要求器械具備持久的動態性能和生物相容性，採購機構優先考慮可靠的供應來源和成本控制，而製造商則面臨著在擴大生產規模的同時，保持產品質量可重複性的壓力。

材料創新、數位化手術整合、日益嚴格的監管以及供應鏈韌性將重新定義植入製造領域的競爭優勢。

整形外科矯形人工替代物領域正經歷變革，這主要歸因於技術、臨床和監管三方壓力的共同作用。材料加工技術的快速發展以及積層製造帶來的精加工技術進步，使得植入能夠實現更嚴格的公差和更精細的表面處理，從而顯著提升骨整合性能和長期耐久性。同時，數位化手術規劃和術中導航技術不斷提高植入幾何形狀和器械相容性方面的性能標準，這就要求器械設計者和軟體供應商之間進行更緊密的合作。

分析新近生效的美國關稅及其對企業營運、採購和臨床等方面的多方面影響。

2025年美國關稅對整形外科鍛造人工替代物系統的採購、製造策略和競爭地位產生了多方面的影響。關稅帶來的成本壓力迫使製造商和經銷商重新評估其關鍵原料和成品組件的籌資策略，許多企業開展短期成本轉嫁分析和長期供應商重組計劃，以維持利潤率和市場進入。

將材料科學、外科應用、產品系列、臨床環境和分銷模式與策略性製造和商業選擇聯繫起來的詳細細分分析

了解細分市場的細微差別對於掌握臨床需求、採購行為和製造能力之間的交集至關重要。本研究從材料維度檢驗了鈷鉻合金、不銹鋼和鈦合金。每種材料都有不同的機械性能和生物相容性，這些都會影響植入的選擇和製造過程設計。鈷鉻合金常用於需要高耐磨性的承重關節。不銹鋼在某些創傷固定應用中仍然是一種經濟有效的選擇。當強度重量比和骨整合至關重要時，鈦合金是首選。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢將影響採購重點、監管方式和製造地決策。

區域趨勢正在塑造競爭格​​局和業務重點，美洲、歐洲、中東和非洲以及亞太地區各有其獨特的促進因素。在美洲，需求與不斷變化的醫保報銷結構以及大型醫療系統在生命週期價值和供應安全方面的整合密切相關。該地區的採購週期通常獎勵已證實有效的臨床結果和服務可靠性，這為能夠展示全面臨床數據包和強大物流能力的製造商創造了機會。

透過冶金創新、垂直整合和一體化商業化模式，策略能力和營運選擇使領先製造商脫穎而出。

在整形外科鍛造關節假體領域，主要企業憑藉研發投入、卓越製造流程和商業性化能力的差異化組合脫穎而出。領先的製造商致力於冶金工藝、表面處理和模組化結構方面的創新，以滿足動態和外科醫生的工作流程需求。這些投入通常輔以有針對性的臨床舉措，旨在支持有關植入耐久性、降低再次手術風險和改善患者報告結果等方面的說法。

在整形外科植入建立永續競爭優勢的優先事項：增強供應鏈韌性、擴大臨床證據、推廣模組化設計以及最佳化商業模式

對於希望將洞察轉化為可衡量優勢的產業領導者而言，一系列切實可行的建議為短期和中期工作提供了切實可行的藍圖。首先，應審查原物料採購情況，並建立夥伴關係以實現供應來源多元化，從而降低關稅和地緣政治動盪帶來的風險。建立雙重採購安排並建構區域生產能力，可以顯著提高大宗採購合約的可靠性，並降低到岸成本波動的風險。

結合從業者訪談、技術文獻綜述、法規梳理和交叉檢驗分析的混合研究途徑，確保了研究結果具有可靠的實務意義。

本分析的調查方法融合了定性專家意見、嚴謹的二手研究以及同行檢驗的證據，以確保得出切實可行的循證結論。主要研究包括對經驗豐富的骨科醫生、醫院採購人員、生產企業高管和分銷合作夥伴進行結構化訪談，以了解真實的臨床偏好、採購決策依據和營運限制。這些從業人員的觀點被綜合起來，用於識別驅動產品選擇的臨床優先事項、手術趨勢和採購行為。

對整形外科植入領域技術創新、監管和採購趨勢以及持續保持領先地位的戰略要務進行綜合概述

總而言之，整形外科矯形人工替代物的市場格局正受到材料和製造技術創新、監管審查力度加大、採購重點轉變以及影響供應鏈設計的區域政策演變等因素的重塑。這些因素凸顯了嚴謹的臨床證據、靈活的製造地以及針對醫院、門診中心和專科診所獨特需求量身定做的商業模式的重要性。那些能夠成功平衡冶金性能和設計差異化投資與確保業務永續營運的企業，將更有能力滿足臨床醫生的期望和醫療服務提供者的採購需求。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依材料類型整形外科鍛造義肢市場

  • 鈷鉻合金
  • 不銹鋼
  • 鈦合金

第9章整形外科鍛造義肢市場：依應用領域分類

  • 第一次手術
  • 重新置換手術
    • 重新置換
    • 膝關節翻修重新置換
    • 肩關節重新置換術

第10章 按產品類型分類的整形外科鍛造義肢市場

  • 足關節移植
  • 髖關節植入
  • 膝關節移植
  • 肩關節關節移植
  • 脊椎移植
    • 籠子和墊片
    • 棒材和板材
    • 螺絲和固定裝置
  • 創傷固定

第11章 依最終用戶分類的整形外科鍛造義肢市場

  • 門診手術中心
  • 醫院
  • 專業整形外科中心

第12章整形外科鍛造義肢市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章整形外科鍛造義肢市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國整形外科鍛造義肢市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國整形外科義肢市場

第16章 中國整形外科鍛造義肢市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ace Osteomedica Pvt. Ltd.
  • Capsur Enterprises Pvt. Ltd.
  • DePuy Synthes
  • Globus Medical, Inc.
  • GPC Medical Ltd.
  • Mars Orthopaedic Pvt. Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Narang Medical Limited
  • NRV OrthoTech Pvt. Ltd.
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Ottobock SE & Co. KGaA
  • RD Forge
  • Sharma Orthopedic（India）Pvt. Ltd.
  • Simplex Orthopaedic Pvt. Ltd.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf.
Product Code: MRR-4F7A6D4FB921

The Orthopedic Forged Protheses Market was valued at USD 6.34 billion in 2025 and is projected to grow to USD 6.89 billion in 2026, with a CAGR of 9.58%, reaching USD 12.04 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.34 billion
Estimated Year [2026] USD 6.89 billion
Forecast Year [2032] USD 12.04 billion
CAGR (%) 9.58%

A concise strategic orientation that synthesizes clinical, manufacturing, and supply dynamics to inform executive decisions in orthopedic forged prostheses

The evolving field of orthopedic forged prostheses occupies a critical intersection of surgical innovation, materials science, and complex supply chain dynamics. Advances in metallurgy, precision manufacturing, and implant design have created an environment in which clinical expectations and commercial imperatives are converging. Surgeons demand devices that offer durable biomechanics and biological compatibility, procurement organizations prioritize reliable sources and cost containment, and manufacturers face mounting pressure to demonstrate reproducible quality while scaling production.

Against that backdrop, this executive summary synthesizes the most consequential shifts and practical implications for stakeholders across the ecosystem. It underscores where technical breakthroughs are making real differences in clinical outcomes, highlights structural forces reshaping procurement and distribution, and frames priority actions for those seeking to maintain competitive advantage. The aim is to present a concise, evidence-based roadmap that helps executives translate technical detail into investment, manufacturing, and commercial choices.

Readers will find analysis that balances clinical relevance with operational reality, articulating how product-level differentiation, regulatory trajectories, and channel strategies intersect to determine market movement. The result is a high-resolution foundation for strategic planning that supports confident decision-making in a market where precision, reliability, and responsiveness define success.

How material innovation, digital surgical integration, regulatory rigor, and supply chain resilience are redefining competitive advantage in implant manufacturing

The landscape for orthopedic forged prostheses is undergoing transformative shifts driven by converging technological, clinical, and regulatory pressures. Rapid advances in material processing and additive-enabled finishing techniques are enabling implants with tighter tolerances and enhanced surface engineering, which in turn influence osseointegration performance and long-term durability. Concurrently, digital surgical planning and intraoperative navigation technologies are raising the performance bar for implant geometries and instrumentation compatibility, demanding closer collaboration between device designers and software providers.

At the same time, supply chain resilience has become a strategic priority, prompting manufacturers to diversify sourcing for raw alloys and to reassess geographically concentrated production footprints. Regulatory frameworks are growing more exacting with respect to traceability, post-market surveillance, and evidence of clinical effectiveness, obliging firms to expand their clinical data programs and quality management investments. Payer and provider procurement behaviors are also evolving; hospitals and ambulatory centers increasingly base procurement on lifecycle cost, service agreements, and evidence of reduced revision rates rather than simple unit price.

These shifts collectively favor manufacturers who can integrate advanced materials expertise with robust clinical validation, agile supply chain management, and digitally enabled product ecosystems. Companies that align R&D, clinical strategy, and commercialization to these structural changes will be better positioned to capture long-term clinical trust and procurement preference as the category continues to mature.

Analyzing the multidimensional operational, procurement, and clinical consequences of newly enacted United States tariffs and how firms are responding

The implementation of United States tariffs in 2025 has created multi-dimensional effects across procurement, manufacturing strategy, and competitive positioning within the orthopedic forged prostheses ecosystem. Tariff-induced cost pressures have required manufacturers and distributors to reassess sourcing strategies for critical raw inputs and finished assemblies, with many organizations conducting near-term cost pass-through analyses and longer-term supplier reconfiguration plans to preserve margin and market access.

Operationally, the tariffs have accelerated discussions around regional manufacturing capacity and localization. Firms that already maintain or can quickly stand up North American processing capabilities have found themselves with a distinct advantage in satisfying hospital purchasing groups that prioritize predictable total landed cost and supply continuity. Simultaneously, original equipment manufacturers have expanded contractual dialogues around risk-sharing with suppliers and customers, introducing service-level agreements and inventory strategies designed to buffer demand volatility tied to tariff fluctuations.

Clinically, payers and procurement committees are scrutinizing value propositions more closely, linking device selection to lifecycle outcomes and potential downstream costs such as revision procedures. This shift intensifies the importance of robust clinical evidence and post-market surveillance programs as differentiators. From a competitive perspective, the tariff environment has opened windows for vertically integrated producers and regional contract manufacturers to increase their relevance to health systems seeking stable supply flows. Firms that can demonstrate transparent cost structures, diversified supply lines, and validated clinical performance will be in the best position to preserve market access and sustain relationships with large institutional buyers.

Deep segmentation analysis linking material science, surgical application, product families, care settings, and distribution modes to strategic manufacturing and commercial choices

A nuanced understanding of segmentation is essential for capturing where clinical need, procurement behavior, and manufacturing capability intersect. The material dimension of the market is examined across cobalt chromium alloy, stainless steel, and titanium alloy, each offering distinct mechanical properties and biocompatibility profiles that influence implant selection and manufacturing process design. Cobalt chromium alloys often serve load-bearing articulations that require high wear resistance, stainless steel continues to be a cost-effective option in certain trauma fixation applications, and titanium alloys are favored where strength-to-weight ratio and osseointegration are critical.

Application-level distinctions separate primary surgery from revision surgery, with revision procedures further examined across hip, knee, and shoulder contexts. Revision surgeries present heightened technical complexity, demand for modularity, and often necessitate tailored inventory strategies due to variability in bone loss and soft-tissue conditions. Product-level segmentation encompasses foot and ankle implant, hip implant, knee implant, shoulder implant, spine implant, and trauma fixation. The foot and ankle category is further differentiated by ankle fusion devices, ligament reconstruction devices, and total ankle replacement products. Hip implant variations include hemiarthroplasty, revision hip replacement, and total hip replacement, while knee implant distinctions cover partial knee replacement, revision knee replacement, and total knee replacement. Shoulder implants are analyzed across partial shoulder replacement, reverse shoulder replacement, and total shoulder replacement. Spine implant analysis spans cages and spacers, rods and plates, and screws and fixation devices. Trauma fixation is disaggregated into external fixators, intramedullary nails, and plates and screws, reflecting the variety of mechanical and logistical requirements across traumatic indications.

End-user segmentation focuses on ambulatory surgical centers, hospitals, and specialty orthopedic centers, each of which carries different purchasing dynamics, procedural volumes, and instrumentation preferences. Distribution channel analysis compares direct sales relationships with distributor sales models, highlighting differences in account control, aftermarket service expectations, and commercial scalability. Taken together, these segmentation lenses enable precise prioritization of clinical investments, manufacturing capabilities, and commercial approaches tailored to specific product families and care settings.

Regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine procurement priorities, regulatory approaches, and manufacturing footprint decisions

Regional dynamics shape both competitive landscapes and operational priorities, with distinct drivers in the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, demand is closely tied to evolving reimbursement structures and the consolidation of large health systems that negotiate on lifecycle value and supply stability. Procurement cycles in this region often reward proven clinical outcomes and service reliability, creating opportunities for manufacturers who can demonstrate comprehensive clinical data packages and strong logistical performance.

The Europe Middle East & Africa region presents a heterogeneous regulatory and reimbursement environment. Within this geography, national procurement practices and regulatory pathways vary widely, compelling manufacturers to adopt adaptable market entry strategies that balance centralized clinical evidence with localized commercial and regulatory engagement. Cost-containment pressures coexist with a high emphasis on clinical efficacy, making strategic partnerships with regional distributors and clinical centers valuable for navigating varied hospital tender processes and regulatory expectations.

Asia-Pacific is characterized by rapid infrastructure expansion, growing elective procedure volumes, and a dynamic mix of domestic and international manufacturers. Markets within this region are increasingly prioritizing localization, technology transfer, and capacity building, while surgeons and hospitals seek implants that align with both global clinical standards and region-specific anatomical or surgical preferences. Across all regions, geopolitical considerations and supply chain resilience continue to affect sourcing decisions, making regional manufacturing footprint and near-term contingency planning important components of competitive strategy.

Strategic capabilities and operational choices that differentiate leading manufacturers through metallurgical innovation, vertical integration, and integrated commercialization models

Key companies operating in the orthopedic forged prostheses segment are distinguishing themselves through differentiated combinations of R&D focus, manufacturing excellence, and commercial reach. Leading manufacturers are investing to advance metallurgical processes, surface treatments, and modular architectures that address both biomechanics and surgeon workflow preferences. These investments are often complemented by targeted clinical initiatives designed to substantiate claims around implant longevity, reduced revision risk, and improved patient-reported outcomes.

On the operational side, successful firms are increasingly integrating vertical capabilities that enhance control over critical raw materials and forging processes while establishing robust quality systems and traceability protocols. This integration improves responsiveness to demand variability and supports stronger supplier relationships. Commercially, companies that pair strong clinical evidence with flexible channel strategies-balancing direct sales models in high-touch hospital accounts with distributor partnerships in fragmented geographies-tend to capture broader adoption across diverse end-user types.

Strategic collaborations are also prominent, with alliances between device manufacturers and surgical technology providers enabling more holistic offerings that combine implants with digital planning, instrumentation, and services. Additionally, companies that prioritize sustainable manufacturing practices and transparent supply chains are gaining favor among institutional buyers focused on long-term procurement risk mitigation. Taken together, these approaches form a pragmatic blueprint for firms seeking to strengthen market position through technical differentiation, operational resilience, and customer-centric commercialization.

Priority actions to strengthen supply resilience, clinical evidence, modular design, and commercial models for sustained competitive advantage in orthopedic implants

For industry leaders aiming to convert insight into measurable advantage, a set of actionable recommendations provides a practical roadmap for near- and medium-term initiatives. Begin by re-evaluating raw material sourcing and forging partnerships to increase supply diversity and reduce exposure to tariff or geopolitical disruptions. Establishing dual-source arrangements or regional production capacity can materially improve reliability for high-volume institutional contracts and mitigate landed-cost volatility.

Second, accelerate investments in clinical evidence generation that directly align with payer and procurement value criteria. Prioritize post-market surveillance, registries, and targeted outcomes studies that demonstrate reductions in revision rates, reduced downstream costs, or faster patient recovery. These data assets not only support procurement conversations but also strengthen regulatory dossiers and physician adoption.

Third, cultivate differentiated product architectures that respond to both primary and revision surgery complexities. Modular designs, adaptable instrumentation, and a focus on material selection that optimizes osseointegration and wear resistance will resonate with surgeons and purchasing committees. Simultaneously, refine commercial models by combining direct account management for high-value customers with distributor-enabled reach in more fragmented markets, ensuring consistent clinical support and service levels.

Finally, institutionalize agility through scenario planning and cross-functional governance that connects commercial, regulatory, and manufacturing teams. Regularly simulate pricing, tariff, and supply shocks to stress-test inventory strategies and contractual protections. By implementing these recommendations, organizations can more effectively manage risk, differentiate clinically, and capitalize on evolving procurement preferences across care settings.

A mixed-methods research approach combining practitioner interviews, technical literature review, regulatory mapping, and cross-validated analysis to ensure robust, actionable insights

The research methodology underpinning this analysis blends qualitative expert input with rigorous secondary research and cross-validated evidence to ensure that insights are actionable and grounded. Primary research included structured interviews with experienced orthopedic surgeons, hospital procurement leaders, manufacturing executives, and distributor partners to capture real-world clinical preferences, purchasing rationales, and operational constraints. These practitioner perspectives were synthesized to identify clinical priorities, surgical trends, and procurement behaviors that drive product selection.

Complementing primary input, secondary research drew on technical literature, regulatory filings, and company disclosures to map material properties, manufacturing practices, and documented clinical outcomes. Where appropriate, device design characteristics and instrumentation requirements were compared against published clinical studies and regulatory summaries to validate claims around performance and safety. Data triangulation and iterative validation sessions with subject-matter experts were used to reconcile divergent perspectives and refine segmentation boundaries.

Analytical procedures included qualitative thematic coding of interview transcripts, cross-regional comparison of regulatory and procurement frameworks, and scenario analysis to evaluate the operational impact of tariffs and supply chain shifts. Quality assurance steps consisted of independent review by domain experts, consistency checks across evidence streams, and a documented audit trail for each major conclusion. This mixed-methods approach ensures that the insights presented are both empirically grounded and practically relevant to executive decision-making.

Concluding synthesis that integrates technical innovation, regulatory and procurement dynamics, and strategic imperatives for sustained leadership in orthopedic implants

In summary, the orthopedic forged prostheses landscape is being reshaped by material and manufacturing innovation, heightened regulatory scrutiny, shifting procurement priorities, and regional policy developments that influence supply chain design. These forces are elevating the importance of rigorous clinical evidence, flexible manufacturing footprints, and commercial models that align with the distinct needs of hospitals, ambulatory centers, and specialty providers. Organizations that balance investment in metallurgical and design differentiation with operational resilience will be better positioned to meet clinician expectations and institutional procurement demands.

Tariff-driven cost pressures and geopolitical uncertainty reinforce the need for deliberate supplier diversification and transparent cost structures, while modular product strategies and targeted clinical programs can drive adoption across both primary and increasingly complex revision surgeries. Regional variation requires tailored approaches; success depends on the ability to localize where necessary and to build partnerships that bridge regulatory and procurement nuances.

Ultimately, the companies that successfully integrate technical excellence, validated clinical outcomes, and agile commercial strategies will capture enduring preference among surgeons and health systems. This executive summary serves as a strategic compass for leaders looking to prioritize investments, refine supply models, and accelerate clinically driven adoption in a market where reliability and evidence are the primary currencies of decision-making.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Orthopedic Forged Protheses Market, by Material Type

  • 8.1. Cobalt Chromium Alloy
  • 8.2. Stainless Steel
  • 8.3. Titanium Alloy

9. Orthopedic Forged Protheses Market, by Application

  • 9.1. Primary Surgery
  • 9.2. Revision Surgery
    • 9.2.1. Hip Revision
    • 9.2.2. Knee Revision
    • 9.2.3. Shoulder Revision

10. Orthopedic Forged Protheses Market, by Product Type

  • 10.1. Foot And Ankle Implant
  • 10.2. Hip Implant
  • 10.3. Knee Implant
  • 10.4. Shoulder Implant
  • 10.5. Spine Implant
    • 10.5.1. Cages & Spacers
    • 10.5.2. Rods & Plates
    • 10.5.3. Screws & Fixation Devices
  • 10.6. Trauma Fixation

11. Orthopedic Forged Protheses Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Hospital
  • 11.3. Specialty Orthopedic Center

12. Orthopedic Forged Protheses Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Orthopedic Forged Protheses Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Orthopedic Forged Protheses Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Orthopedic Forged Protheses Market

16. China Orthopedic Forged Protheses Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ace Osteomedica Pvt. Ltd.
  • 17.6. Capsur Enterprises Pvt. Ltd.
  • 17.7. DePuy Synthes
  • 17.8. Globus Medical, Inc.
  • 17.9. GPC Medical Ltd.
  • 17.10. Mars Orthopaedic Pvt. Ltd.
  • 17.11. Medtronic plc
  • 17.12. Meril Life Sciences Pvt. Ltd.
  • 17.13. Narang Medical Limited
  • 17.14. NRV OrthoTech Pvt. Ltd.
  • 17.15. NuVasive, Inc.
  • 17.16. Orthofix Medical Inc.
  • 17.17. Ottobock SE & Co. KGaA
  • 17.18. R D Forge
  • 17.19. Sharma Orthopedic (India) Pvt. Ltd.
  • 17.20. Simplex Orthopaedic Pvt. Ltd.
  • 17.21. Smith & Nephew plc
  • 17.22. Stryker Corporation
  • 17.23. Zimmer Biomet Holdings, Inc.
  • 17.24. Ossur hf.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COBALT CHROMIUM ALLOY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COBALT CHROMIUM ALLOY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COBALT CHROMIUM ALLOY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TITANIUM ALLOY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TITANIUM ALLOY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TITANIUM ALLOY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRIMARY SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRIMARY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRIMARY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY FOOT AND ANKLE IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY FOOT AND ANKLE IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY FOOT AND ANKLE IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HIP IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY KNEE IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SHOULDER IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY CAGES & SPACERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY CAGES & SPACERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY CAGES & SPACERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY RODS & PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY RODS & PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY RODS & PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SCREWS & FIXATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SCREWS & FIXATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SCREWS & FIXATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TRAUMA FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TRAUMA FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY TRAUMA FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY REVISION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY SPINE IMPLANT, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ORTHOPEDIC FORGED PROTHESES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)